Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study.
Ruijter BN, Inderson A, van den Berg AP, Metselaar HJ, Dubbeld J, Tushuizen ME, Porte RJ, Polak W, van der Helm D, van Reeven M, Rodriguez-Girondo M, van Hoek B. Ruijter BN, et al. Among authors: tushuizen me. J Clin Transl Hepatol. 2023 Aug 28;11(4):839-849. doi: 10.14218/JCTH.2022.00348. Epub 2023 Mar 7. J Clin Transl Hepatol. 2023. PMID: 37408814 Free PMC article.
Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment.
van den Beukel MD, Stoelinga AEC, van der Meer AJ, van der Meulen S, Zhang L, Tushuizen ME, van Hoek B, Trouw LA. van den Beukel MD, et al. Among authors: tushuizen me. Front Med (Lausanne). 2023 Jul 25;10:1195747. doi: 10.3389/fmed.2023.1195747. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37564051 Free PMC article.
Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment.
van den Beukel MD, Stoelinga AEC, van der Meer AJ, van der Meulen S, Zhang L, Tushuizen ME, van Hoek B, Trouw LA. van den Beukel MD, et al. Among authors: tushuizen me. Front Med (Lausanne). 2023 Oct 23;10:1297191. doi: 10.3389/fmed.2023.1297191. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37937138 Free PMC article. No abstract available.
Intraprocedural assessment of ablation margins using computed tomography co-registration in hepatocellular carcinoma treatment with percutaneous ablation: IAMCOMPLETE study.
Hendriks P, van Dijk KM, Boekestijn B, Broersen A, van Duijn-de Vreugd JJ, Coenraad MJ, Tushuizen ME, van Erkel AR, van der Meer RW, van Rijswijk CS, Dijkstra J, de Geus-Oei LF, Burgmans MC. Hendriks P, et al. Among authors: tushuizen me. Diagn Interv Imaging. 2024 Feb;105(2):57-64. doi: 10.1016/j.diii.2023.07.002. Epub 2023 Jul 28. Diagn Interv Imaging. 2024. PMID: 37517969 Free article.
Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort.
Liem SIE, Ciaffi J, van Leeuwen NM, Boonstra M, Ahmed S, Beaart-van de Voorde LJJ, Corsel A, Dhondai T, Ninaber MK, Geelhoed-Veltman JJM, Heuvers ME, Tushuizen ME, Ajmone Marsan N, Kiès P, Schouffoer AA, Huizinga TWJ, Allaart CF, De Vries-Bouwstra J. Liem SIE, et al. Among authors: tushuizen me. RMD Open. 2023 Apr;9(2):e002971. doi: 10.1136/rmdopen-2022-002971. RMD Open. 2023. PMID: 37028816 Free PMC article.
The impact of CYP2C19 genotype on phenoconversion by concomitant medication.
de Jong LM, Boussallami S, Sánchez-López E, Giera M, Tushuizen ME, Hoekstra M, Hawinkels LJAC, Rissmann R, Swen JJ, Manson ML. de Jong LM, et al. Among authors: tushuizen me. Front Pharmacol. 2023 Jun 8;14:1201906. doi: 10.3389/fphar.2023.1201906. eCollection 2023. Front Pharmacol. 2023. PMID: 37361233 Free PMC article.
95 results